Investigation into the Specificity of Angiotensin II-induced Behavioral Desensitization by Vento, Peter J et al.
Bucknell University
Bucknell Digital Commons
Faculty Journal Articles Faculty Scholarship
2012
Investigation into the Specificity of Angiotensin II-
induced Behavioral Desensitization
Peter J. Vento
SUNY Buffalo
Kevin P. Myers
Bucknell University, kmyers@bucknell.edu
Derek Daniels
SUNY Buffalo
Follow this and additional works at: https://digitalcommons.bucknell.edu/fac_journ
Part of the Behavioral Neurobiology Commons, and the Biological Psychology Commons
This Article is brought to you for free and open access by the Faculty Scholarship at Bucknell Digital Commons. It has been accepted for inclusion in
Faculty Journal Articles by an authorized administrator of Bucknell Digital Commons. For more information, please contact dcadmin@bucknell.edu.
Recommended Citation
Vento, Peter J.; Myers, Kevin P.; and Daniels, Derek. "Investigation into the Specificity of Angiotensin II-induced Behavioral
Desensitization." Physiology & Behavior (2012) : 1076-1081.
Investigation into the speciﬁcity of angiotensin II-induced behavioral desensitization
Peter J. Vento a, Kevin P. Myers b, Derek Daniels a,⁎
a Behavioral Neuroscience Program, Department of Psychology, The State University of New York at Buffalo, Buffalo, NY 14260, USA
b Department of Psychology, Bucknell University, Lewisburg, PA 17837, USA
a b s t r a c ta r t i c l e i n f o
Article history:
Received 25 October 2011
Received in revised form 5 December 2011
Accepted 6 December 2011
Keywords:
Angiotensin
Thirst
Desensitization
Angiotensin II (AngII) plays a key role in maintaining body ﬂuid homeostasis. The physiological and behavioral
effects of central AngII include increased blood pressure and ﬂuid intake. In vitro experiments demonstrate
that repeated exposure to AngII reduces the efﬁcacy of subsequent AngII, and behavioral studies indicate that
prior icv AngII administration reduces the dipsogenic response to AngII administered later. Speciﬁcally, rats
given a treatment regimen of three icv injections of a large dose of AngII, each separated by 20 min, drink less
water in response to a test injection of AngII than do vehicle-treated controls given the same test injection.
The present studies were designed to test three potential explanations for the reduced dipsogenic potency of
AngII after repeated administration. To this end, we tested for motor impairment caused by repeated injections
of AngII, for a possible role of visceral distress or illness, and for differences in the pressor response to the
ﬁnal test injection of AngII. We found that repeated injections of AngII neither affected drinking stimulated
by carbachol nor did they produce a conditioned ﬂavor avoidance. Furthermore, we found no evidence that
differences in the pressor response to the ﬁnal test injection of AngII accounted for the difference in intake.
In light of these ﬁndings, we are able to reject these three explanations for the observed behavioral desen-
sitization, and, we suggest instead that the mechanism for this phenomenon may be at the level of the
receptor.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
Angiotensin II (AngII) is a peptide that is critically involved in the
coordinated responses to hypovolemia, including increased blood
pressure and the stimulation of water and salt intake [1]. The cardiovas-
cular and behavioral actions of AngII have been shown to be primarily
mediated by the angiotensin type 1 (AT1) receptor [2–6]. Previous
research suggests that AT1 receptor activation leads to receptor desen-
sitization [7–12] and this may be an important component of normal
AngII functioning [13]. Much of this research, however, has used in
vitro preparations to investigate receptor function. Therefore, less is
known about AngII-induced desensitization in the behaving animal
and whether these in vitro ﬁndings extend to in vivomodels.
Repeated icv injections of AngII result in a desensitization of the
dipsogenic [14–17] and renal [17] responses to the peptide. Our lab
has shown that rats given a treatment regimen of three icv injections
of AngII over a short period of time, drink less water after a ﬁnal test
injection of AngII thando rats that received a control treatment regimen
before the sameﬁnal test injection [16].We showed that this behavioral
desensitization is mediated by the AT1 receptor, relatively short lasting,
and speciﬁc to AngII-induced water intake because intake of 1.5% saline
was unaffected in a two-bottle test [16]. These previous ﬁndings are
consistent with the idea that this phenomenon is regulated at the
level of the receptor. Nevertheless, several alternative explanations
could account for the observed differences in drinking behavior.
In the present study, we investigated several possible explanations
that could account for the reducedwater intake that occurs after repeated
AngII administration. First, the reduction in water intake could reﬂect a
motor impairment. If this were the case, we would expect drinking
induced by other dipsogens to be affected similarly. To test this, we
examined the effect of repeated injections of AngII on water intake
stimulated by the cholinergic agonist, carbachol. Second, repeated
injections of AngII may cause visceral distress or malaise, which could
inhibit subsequent intake. This would be evidenced by the acquisition
of a learned avoidance of a novel ﬂavor paired with the repeated drug
administration. Thus, we evaluated the development of conditioned
ﬂavor preference or avoidance for a novel ﬂavor that was paired with
repeated injections of AngII. Third, because AngII-induced ﬂuid intake
can be inhibited by hypertension [18], a sensitized pressor response to
repeated AngII could explain the reduced water intake. Therefore,
we continuously measured blood pressure during and after repeated
injections of AngII to determine if an exaggerated pressor response
paralleled the reducedwater intake observed in our behavioral studies.
Taken together, the results suggest that AngII-induced behavioral
desensitization is not the result of these less speciﬁc inhibitory effects
on water intake, but, instead, more likely reﬂects cellular changes con-
sistent with receptor desensitization.
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2. Materials and methods
2.1. Experimental animals
Adult male Sprague Dawley rats were obtained from Harlan Labo-
ratories (Indianapolis, IN; 175–199 g). Rats were maintained in a
temperature- and humidity-controlled room in hanging stainless
steel, wire-mesh cages on a 12:12 h light:dark cycle. All rats had ad
libitum access to standard rat chow and tap water, unless otherwise
stated. The handling and care of laboratory animals conformed to the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals. All experimental protocols were approved by the Institutional
Animal Care and Use Committee of the State University of New York at
Buffalo.
2.2. Lateral ventricle cannula implantation
No fewer than 5 days after arrival from the breeder, rats were
anesthetized by intramuscular injection of a combination of ketamine
(70 mg/kg) and xylazine (5 mg/kg). Chronic indwelling cannulae aimed
at the lateral ventricle (coordinates: 0.9 mm posterior to bregma,
1.4 mm lateral to midline, 1.8 mm ventral to dura) were implanted and
afﬁxed to the skull with bone screws and dental cement. Septocaine
with epinephrine (topical) and carprofen (5 mg/kg, sc)were usedduring
the surgery for analgesia. No fewer than 5 days after surgery, proper
cannula placement and AngII responsiveness were veriﬁed by injection
of 10 ng AngII, and only those animals that drank at least 6 ml in the
30 min after the injection were included in the experiments.
2.3. Drug injections and intake measures
AngII (Bachem Bioscience Inc., King of Prussia, PA) and carbachol
(Sigma-Aldrich Corp, St. Louis, MO) were diluted in Tris-buffered
saline (TBS). All experiments were performed early in the light portion
of the light:dark cycle. Injections were made through a 33 gauge in-
jection cannula that extended beyond the guide cannula into the
lateral ventricle. The injector was connected to water-ﬁlled PE 50
tubing attached to a 10 μl Hamilton syringe (Hamilton Company,
Reno, NV). Each injection was 1 μl and the injection cannulae
were left in place for approximately 30 s after each injection. For
clarity, experimental injections are collectively referred to as the
“treatment regimen” and the ﬁnal challenge injection as the “test”
injection. In all cases, the treatment regimen comprised three in-
jections of either AngII (300 ng) or vehicle (TBS), with each injec-
tion separated by 20 min. The test injection was a single injection
of either AngII (100 ng), carbachol (150 nM), or vehicle (TBS) given
20 min after the ﬁnal treatment regimen injection. In most experiments,
food and water were removed immediately before the start of the treat-
ment regimen and returned after the test injection. In the experiment
measuring blood pressure, food and water were not returned until
pressure recordings had ended.
Total water intake during the testing period was calculated as the
difference in pre- and post-test water bottle weight. The temporal
distribution of intake was assayed by counting licks in discrete 10 min
intervals using a contact lickometer (designed and constructed by the
Psychology Electronics Shop, University of Pennsylvania, Philadelphia,
PA). The lickometer interfaced with a computer using an integrated
USB digital I/O device (National Instruments, Inc., Austin, TX) and was
processed in a MATLAB (MathWorks, Natick, MA) software environ-
ment before being ported to Excel (Microsoft Corp, Redmond, WA) for
ﬁnal analysis. Water spouts were behind an electrically isolated metal
plate with a 3.2 mm-wide opening through which the rat needed to
lick to reach the spout,minimizing the possibility of non-tongue contact
with the spout.
2.4. Flavor preference testing
Rats were tested for ﬂavor preference conditioning in two different
ways. First, rats were given either an AngII or a vehicle treatment
regimen prior to all rats receiving a test injection of AngII. After the
test injection, rats were returned to their cages and given access to
a bottle containing 4 ml of either 0.4% almond or 0.4% vanilla extract
(McCormick; McCormick & Co., Inc., Hunt Valley, MD) diluted in tap
water. Because we expected rats in the AngII treatment regimen
group would drink less than controls, we limited all rats to 4 ml of
the ﬂavored water to help keep exposure to the two ﬂavors consistent
between groups and, therefore, minimize any potential confounding
inﬂuence of differential familiarization. If a rat consumed the entire
4 ml before the end of the session, the ﬂavored water was replaced
with normal tap water for the remainder of the 30 min intake phase.
Three days later, each rat received the other treatment regimen (TBS
or AngII) prior to a test injection of AngII and was given access to
the previously unexposed ﬂavor. Each rat received both treatment
regimens and was exposed to both ﬂavors, but only one ﬂavor was
paired with the AngII treatment regimen for any given animal. The
order of treatment regimen and which ﬂavor was associated with
the vehicle or the AngII treatment regimen were each counterba-
lanced. Three days after the second conditioning trial, rats were
injected with 10 ng AngII (icv) and tested for ﬂavor preference in a
two-bottle test (0.4% almond or 0.4% vanilla extract in tap water;
for timeline see Fig. 2A). Location of the bottles containing the ﬂa-
vored water was counterbalanced to control for any left/right
preference.
Due to relatively low intakes in the preference test by some rats
in the preceding experiment, a separate experiment was conducted
to address concerns that a ﬂoor effect may have obscured any condi-
tioned preference. This experiment was designed to promote higher
baseline consumption and eliminate the need for AngII injection
during the ﬁnal preference test. Rats were habituated to 1 h of water
access per day for 7 days and maintained on this drinking schedule
until the end of the experiment. After habituation, rats received either
an AngII or a vehicle treatment regimen before all rats received a ﬁnal
test injection of AngII. Immediately after the test injection, rats were
given 30-min access to a bottle containing either vanilla- or almond-
ﬂavored water. Two days later, rats received the opposite treatment
regimen (TBS or AngII) before a test injection of AngII and were
given access to the previously unexposed ﬂavor (for timeline see
Fig. 3A). Order of treatment regimen and treatment regimen-paired
ﬂavor were counterbalanced. Tap water was provided each day after
the experiment for 1 h. Two days after the second conditioning trial,
rats were given access to the two bottles of ﬂavored water, at the
time when they otherwise would have received their daily drinking
water, and intake was measured. Location of the bottles containing
the ﬂavored water was counterbalanced to control for any left/right
preference.
2.5. Blood pressure recordings
Blood pressurewasmeasured by tail-cuff volume pressure recording
(CODAMonitor; Kent Scientiﬁc Corporation, Torrington, CT). Brieﬂy, rats
were anesthetized by inhaled isoﬂurane immediately before blood
pressure recording started. After 20 min of baseline recordings, rats
received either an AngII or a vehicle treatment regimen 20 min before
a test injection of either AngII or vehicle. Body temperature was
maintained at approximately 38 °C using an automated temperature
monitoring system (Physitemp Instruments Inc., Clifton, NJ). Blood
pressure recordings were taken at a frequency of once per min
throughout the course of the injection procedure and for 30 min
after the ﬁnal test injection. For each subject, change in mean blood
pressure was calculated as mean blood pressure minus baseline
blood pressure. Baseline blood pressure was calculated as the mean
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pressure over 5 min of recordings taken immediately before the
ﬁrst treatment regimen injection. With the exception of baseline
measures, all data are reported as change in mean blood pressure
(mean±SEM).
2.6. Data analysis
Data were analyzed using Statistica software (version 9.0; Statsoft,
Tulsa, OK). Two-way repeated measures ANOVA was used to test for
treatment-related differences in non-cumulative licks and change in
mean blood pressure. One-way ANOVA was used to analyze baseline
blood pressure, change in blood pressure at the last measure before
the test injection, and peak change in pressure after the test injection.
Statistically signiﬁcant main or interaction effects (pb0.05) were
further analyzed using Student Neuman–Keuls post hoc tests. Student's t
tests were used to analyze 30 min ﬂuid intake.
3. Results
3.1. Repeated injections of AngII did not affect carbachol-induced water
intake
Rats received either an AngII or a vehicle treatment regimen before
a test injection of AngII or carbachol (for timeline see Fig. 1A). When
rats were given a test injection of AngII, we did not detect a signiﬁcant
main effect of Condition (F1,8=5.06, p>0.05), but we found a signiﬁ-
cant Time×Condition interaction (F2,16=4.67, pb0.05, n=4–6 per
group; Fig. 1B). Analysis of individual time bins revealed that this effect
was most prominent at 10 min after the test injection (pb0.05), at
which time rats given an AngII treatment regimen licked the water
spout less than did rats given a vehicle treatment regimen. Measures
of total 30 min water intake also revealed less water intake by rats
in the AngII treatment regimen group than by controls (t=3.338,
pb0.05; Fig. 1C). We found no difference, however, in non-cumulative
licks (main effect of Condition, F1,12=4.24, p>0.05; Time×Condition
interaction, F2,24=1.06, p>0.05; Fig. 1D) or total water intake (t=
1.14, p>0.05; Fig. 1E) by rats that received either an AngII or a vehicle
treatment regimen prior to a test injection of carbachol.
3.2. Repeated injections of AngII did not produce a conditioned ﬂavor
avoidance
Rats were administered either an AngII or a vehicle treatment regi-
men prior to a test injection of AngII, and were given access to a novel
ﬂavor diluted in their drinking water. Three days after the completion
of this training phase, rats were tested for preference/avoidance of the
treatment regimen-paired ﬂavors in a two-bottle preference test after
ﬂuid intake was stimulated by a single injection of AngII (10 ng).
Rats showed a tendency to prefer, rather than avoid, the ﬂavor
previously consumed after the AngII treatment regimen. Analysis of
non-cumulative licks revealed a signiﬁcant main effect of Flavor
(F1,38=4.909, pb0.05, n=20 per group; Fig. 2B) and a signiﬁcant
Time×Flavor interaction (F2,76=4.429, pb0.05). Post hoc analysis of
individual time bins determined that this effect was most prominent
10 min after the injection, at which time rats licked more at the spout
containing the ﬂavor previously paired with the AngII treatment reg-
imen (pb0.05). Total intake in the 30 min test did not, however, differ
signiﬁcantly (t=2.005, p>0.05; Fig. 2C).
In a second set of experiments, consumption in the ﬁnal two-bottle
preference test was stimulated by water restriction (1 h/day access)
instead of by AngII injection. Here, rats showed no evidence of
learned avoidance of or preference for the ﬂavor previously paired
with the AngII treatment regimen. We found no effect of Flavor on
non-cumulative licks (main effect of Flavor, F1,20=0.895, p>0.05;
Time×Flavor interaction, F2,40=0.321, p>0.05; n=11 per group;
Fig. 3B) or on total intake between groups (t=1.072, p>0.05; Fig. 3C).
3.3. Repeated injections of AngII did not enhance the pressor response to
an AngII test injection
Elevated blood pressure inhibits AngII-induced water intake [19].
Therefore, an enhanced pressor response to repeated injections of
AngII could explain the observed differences in water intake. To test
this hypothesis, we recorded blood pressure in rats given either an
AngII or a vehicle treatment regimen prior to a test injection of
AngII. A third group of rats received a vehicle treatment regimen
prior to a vehicle test injection. We found no statistical difference in
baseline blood pressure between groups (main effect of Condition,
F2,19=1.782, p>0.05, n=7–8 per group; Table 1). Pressure record-
ings over the course of the treatment regimen revealed a signiﬁcant
main effect of Condition (F2,18=9.791, pb0.05; Fig. 4A) and post hoc
tests conﬁrmed that blood pressure was elevated in rats that received
an AngII treatment regimen. We did not detect a signiﬁcant Time×
Condition interaction (F118,1062=1.125, p>0.05) in the time before
the test injection. As expected, we found no signiﬁcant differences
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Fig. 1. Repeated injections of AngII caused a reduction in AngII-stimulated water
intake, but had no effect on carbachol-induced intake. (A) The timeline used for
the experiment. Rats were given an AngII or a vehicle treatment regimen before a test in-
jection of AngII or carbachol. (B) The number of licks by rats given repeated injections of
AngII was less than it was by rats in the control group after both groups received a test
injection of AngII ( pb0.05; n=4–6 per group). (C) Rats in the AngII treatment regimen
group also drank less over the entire 30 min test (pb0.05). (D) We found no between-
group differences in non-cumulative licks (p>0.05, n=7 per group) after a test injection
of carbachol. (E) No between-group differences in 30 min intake were found after a test
injection of carbachol (p>0.05).
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in blood pressure over the course of the treatment regimen injections
between the two groups of rats that received vehicle treatment regi-
mens. Analysis of the ﬁnal blood pressure measure taken before the
test injection indicated that blood pressure remained elevated at
this time in the rats that received an AngII treatment regimen (main
effect of Condition, F2,19=5.945, pb0.05; Table 1). Analysis of blood
pressure after the test injection revealed a signiﬁcant main effect of
Condition (F2,19=9.965, pb0.05, n=7–8 per group; Fig. 4B) and a
signiﬁcant Time×Condition interaction (F10,95=2.59, pb0.05). Post
hoc tests on the interaction found differences in the response to the
test injection (vehicle vs. AngII) in rats given a vehicle treatment reg-
imen. Speciﬁcally, the AngII test injection caused an increase in blood
pressure at all of the times tested (pb0.05). Rats given an AngII treat-
ment regimen, however, had a pressor response to a test injection of
AngII that did not differ signiﬁcantly from either of the other two
groups (p>0.05); however, when we limited our analysis to the peak
change in pressure after the test injection, we found that both groups
of rats that received an AngII test injection differed from controls, but
not from each other (F2,19=12.803, pb0.05; Table 1).
4. Discussion
The present experiments tested three potential reasons that rats
given repeated injections of AngII drink less water than do rats given
a single injection of AngII. We found no support for any of these expla-
nations, suggesting that this behavioral desensitization results from a
more speciﬁc tachyphylaxis. Moreover, these data are consistent with
the hypothesis that the changes in behavior reﬂect an underlying
change in AngII receptor function.
Consistent with a previous report [14], we found that repeated
injections of AngII caused a reduction in AngII-induced water intake,
but water intake stimulated by an injection of carbachol was unaffect-
ed. Because carbachol-induced drinking is independent from intake
stimulated by AngII, this ﬁnding suggests that the behavioral desensiti-
zation is speciﬁc to the angiotensin system. If the reduction in AngII-
stimulated water intake after an AngII treatment regimen were the
result of some broader behavioral or motor deﬁcit, water intake
would have been equally affected by repeated injections of AngII
in rats given a test injection of AngII or of carbachol. The data did not,
however, support this possibility because repeated injections of AngII
only affected drinking stimulated by a test injection of AngII. Taken
together with our previous ﬁnding that a repeated AngII treatment
regimen did not affect saline intake [16], it seems unlikely that a
more general motor impairment or broader behavioral deﬁcit
accounted for the effect of repeated injections of AngII.
Although carbachol-induced drinking would likely be affected by
any treatment that caused a more general negative effect, such as
malaise or visceral distress, we wanted to consider additional testing
paradigms to address this possibility. To this end, we used well-
established ﬂavor conditioning procedures [20] to evaluate any positive
or negative associations conditioned by the repeated injections of AngII.
These experiments failed to ﬁnd evidence for a negative association
between the novel ﬂavor and repeated injections of AngII. To the
contrary, in one of the two testing conditions used, rats appeared
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Table 1
Baseline mean blood pressure, change in mean pressure immediately before the test
injection, and peak change in mean pressure after the test injection. Statistically signiﬁcant
differences (pb0.05) from rats receiving only vehicle (vehicle treatment regimen and
vehicle test injection) are noted by an asterisk within each measure.
Condition Mean baseline Δ mean pressure
before test injection
Peak Δ mean pressure
after test injection
Vehicle/Vehicle 76.89±4.54 1.26±1.46 4.69±1.60
Vehicle/AngII 68.13±2.39 3.5±1.10 12.75±1.12*
AngII/AngII 73.59±3.05 7.27±1.02* 10.56±0.52*
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to prefer the ﬂavor that had been paired with repeated injections of
AngII. When rats were tested under conditions of scheduled water
access, however, we found no differences in the number of licks or
intake of the two ﬂavors. A potential explanation for the different
results may relate to state-dependent learning. Tasks learned during
exposure to particular drugs, for example, are performed better
while exposed to those same drugs than in the absence of the drug
[21]. It is possible that the development of a preference would be
speciﬁc to times while AngII levels were elevated as they were dur-
ing the conditioning trials. Accordingly, when intake during the
preference test was stimulated by ﬂuid restriction, instead of by
AngII injection, the difference in AngII exposure created a different
context from that during conditioning, thus a preference was no
longer apparent. This type of state-dependent learning of ﬂavor
preferences has been documented previously using differences in
deprivation state. For example, when rats are food-deprived, they
display a preference for a non-nutritive ﬂavor that had previously
been paired with protein repletion. Moreover, this preference is at-
tenuated by a protein preload, but not a carbohydrate preload [22].
Perhaps more relevant to the present study, Holman demonstrated
that water-deprived rats preferred a ﬂavored water that had been
paired with water intake under a similar deprivation state, but this
preference was not expressed when the rats were not water de-
prived [23]. Nevertheless, the rats in the present studies never
showed evidence of an aversion to the ﬂavor paired with repeated
injections of AngII and we, therefore, reject the hypothesis that a
more general aversive effect is responsible for the reduced intake
observed after a treatment regimen of AngII.
Central injection of AngII increases blood pressure [24], and hy-
pertension can inhibit water intake stimulated by central AngII
[18,19]. If repeated injections of AngII led to a sensitized response
to the test injection, the exaggerated change in blood pressure
could explain the differences in water intake. To test this hypothesis,
we measured blood pressure in rats given repeated injections of
AngII or vehicle before a test injection of AngII and compared the
pressor response to controls given only vehicle. The results of this
experiment did not support the hypothesis because we did not de-
tect any difference in the AngII-induced pressor response in rats
that received an AngII or a vehicle treatment regimen. Analysis of
peak change in pressure after the test injection found that both
groups receiving an AngII test injection had changes in blood pres-
sure greater than those observed after a vehicle test injection.
When the analysis included all measures after the test injection,
however, we did not ﬁnd differences between the group receiving
repeated injections of AngII and rats receiving only vehicle. This
suggests that the AngII treatment regimen attenuated the pressor
response to the ﬁnal AngII test injection, but caution is needed
when drawing this conclusion because there were no statistically
signiﬁcant differences detected between the two groups given a
test injection of AngII. It is important to note, however, that any ef-
fect of the repeated injections of AngII, even though not statistically
signiﬁcant, was in the opposite direction from that which would
cause decreases in intake. Nevertheless, these data warrant further
investigation to determine if repeated injections of AngII affect the
pressor response, but it is clear that the decrease in water intake
caused by repeated AngII administration cannot be explained by a
sensitized pressor response to the ﬁnal AngII test injection.
Additional studies have been able to produce an almost complete
suppression of water intake using lower doses of AngII and fewer
injections [15,17], but a major difference exists between the methods
used in these studies and those reported here and previously by our
laboratory [16]: we do not allow the rats to drink over the course of
the injection protocol. Although previous studies have attempted to
control for the effects of water intake by providing a gastric preload
or an open gastric ﬁstula, these studies do not account for the intake-
suppressive effects of water in the mouth and throat [25], nor do they
control for the possibility that the act of drinking provides negative
feedback. Regardless of differences in the magnitude of the response
or the doses of AngII needed to suppress drinking in the various studies,
the literature collectively provides strong evidence that rats given
repeated injections of AngII drink less water than is consumed by
rats given a single injection of AngII. The present data indicate that
this difference in intake is not due to a more generalized behavioral
suppression or motor deﬁcit, the generation of a negative affective
response, or differences in blood pressure.
5. Conclusions
The present study investigated the speciﬁcity of AngII-induced
behavioral desensitization. We found that this phenomenon appears
to be speciﬁc to the angiotensin system because rats drank less water
in response to a test injection of AngII after prior exposure to an
AngII treatment regimen, but water intake stimulated by the choliner-
gic agonist carbachol was unaffected. Furthermore, it is unlikely that
AngII-induced behavioral desensitization is the result of some aversive
consequence of the repeated AngII treatment regimen because rats did
not avoid a novel ﬂavor that was paired with an AngII treatment regi-
men, and at least under certain testing conditions it appears that rats
prefer the ﬂavor paired with repeated injections of AngII. Finally, we
showed that this behavioral desensitization is not explained by differ-
ences in blood pressure at the time when the intake occurs because
there was no difference in the pressor response to a test injection of
AngII in rats that received an AngII or a vehicle treatment regimen.
Taken together, the ﬁndings rule out these alternative explanations
Fig. 4. The pressor response to vehicle or AngII after repeated injections of vehicle or
AngII. Rats were given either an AngII or a vehicle treatment regimen prior to a test
injection of either AngII or vehicle. (A) The AngII treatment regimen caused an elevated
pressor response that was greater than that by rats given a vehicle treatment regimen
(pb0.05, n=7–8 per group). Vertical dashed lines are used to show the timing of injec-
tions. (B) In response to a test injection of AngII, rats given a vehicle treatment regimen
had a reliable pressor response (pb0.05 vs. vehicle test injection); however, the response
to the same test injection of AngII by rats in the AngII treatment regimen group was not
statistically signiﬁcant compared with either negative controls (vehicle treatment regi-
men and vehicle test injection) or positive controls (vehicle treatment regimen and
AngII test injection; p>0.05). The key shown in panel A applies to panel B.
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and are consistent with the hypothesis that the observed behavioral
desensitization reﬂects an underlying change in AngII responsiveness.
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